Stephanie Kennan on Prescription Drugs

Washington Healthcare Update - September 2019 #3

This week in Washington: Hearings on the public health impact of e-cigarettes, making prescription drugs more affordable and promoting healthy aging. ...more

9/24/2019 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Employee Retirement Income Security Act (ERISA) , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Washington Healthcare Update - September 2019 #1

This week in Washington: Senate to markup the Labor, Health and Human Services, Education and Related Agencies Appropriations Act; House to hold hearings on improving maternal health and the Administration's apparent...more

9/10/2019 / Ambulatory Surgery Centers , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Insurance , IRS , Opioid , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , SAMHSA

Washington Healthcare Update - August 2019 #2

Congress - House - In Recess - Cummings and Sanders Seek Information About Possible Obstruction of a Congressional Investigation on Generic Drug Prices...more

8/20/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Generic Drugs , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - August 2019 #1

Congress - House - House Passes Short-Term Funding Extension for Medicaid Pilot Program - On July 30, the House passed a bill to keep a $1 billion Medicaid pilot providing mental health and addiction services running...more

8/6/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , Medicaid , Medicare , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Trump Administration

Washington Healthcare Update July 2019 #3

This week in Washington: The House is out for summer recess; Senate is in session until the end of this week....more

7/29/2019 / Biologics , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid , Mental Health , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update July 2019 #2

This week in Washington: Senate to hold hearings on the enforcement of antitrust laws and elder justice, while the House plans to hold a member day hearing and examine the Social Security 2100 Act....more

7/23/2019 / Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medical Marijuana , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Washington Healthcare Update June 2019 #4

This week in Washington: Congress is in recess for the July 4th holiday. Upcoming Hearings/Markups... ...more

7/2/2019 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Mental Health , Prescription Drugs , Trump Administration

Washington Healthcare Update June 2019 #3

This week in Washington: Senate to hold hearing on the enforcement of antitrust laws, while the House plans to cover a number of health care bills that reauthorize a variety of health programs for Americans. The House may...more

6/25/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Opioid , Prescription Drugs

Washington Healthcare Update June 2019 #2

This week in Washington: The Senate continues to hold hearings on the cost of health care, the House will hold hearings on the federal approach to opioid treatment and strengthening health care in the U.S. territories. ...more

6/18/2019 / Birth Control , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Inpatient Prospective Payment System (IPPS) , Opioid , Popular , Prescription Drugs , Surprise Medical Bills , Trump Administration

Washington Healthcare Update June 2019 #1

This week in Washington: Senate to consider state of patent eligibility in America, House Ways and Means Committee will hold a hearing on the single-payer issue and both the House and Senate continue to hold hearings on the...more

6/11/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Hospitals , Inpatient Prospective Payment System (IPPS) , Medicaid , Physician-Owned Hospitals , Popular , Prescription Drugs , Surprise Medical Bills

Pay for Delay Passes House of Representatives for First Time

As Congress focuses on how to drive down drug prices, there is bipartisan support for prohibiting reverse payment agreements, also known as “pay-for-delay” arrangements. These arrangements involve a brand-name pharmaceutical...more

5/29/2019 / Federal Trade Commission (FTC) , Generic Drugs , Pay-For-Delay , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update May 2019 #3

This week in Washington: House to hold hearings on surprise medical billing, drug pricing transparency and a single-payer health system....more

5/21/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Inpatient Prospective Payment System (IPPS) , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update May 2019 #2

This week in Washington: House to hold hearings on PFAS contamination and exposure, the maternal mortality crisis and single-payer issues....more

5/14/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Congressional Budget Office , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Inpatient Prospective Payment System (IPPS) , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Pharmacy Benefit Manager (PBM) , Popular , Prescription Drugs , Trump Administration

Washington Healthcare Update May 2019

This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing...more

5/7/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Inpatient Prospective Payment System (IPPS) , Medicare , Medicare for All , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Popular , Prescription Drugs , Trump Administration

Washington Healthcare Update April 2019 #5

Upcoming Hearings/Markups - Tuesday, April 30, 2019 - House Committee on Rules: “Hearing on the Medicare for All Act of 2019,” H.R. 1384 - The House Committee on Rules will hold a hearing on the Medicare for All Act...more

4/30/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Inpatient Prospective Payment System (IPPS) , Medicare Part B , Medicare Part D , Prescription Drugs , Proposed Rules

Washington Healthcare Update April 2019 #4

Congress - Hearings/Markups - House Judiciary Committee: "TBA Markup on CREATES Act, Pay-for-Delay Legislation" - The House Judiciary Committee is planning a markup on the CREATES Act and pay-for-delay legislation....more

4/23/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Durable Medical Equipment , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Healthcare Facilities , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update April 2019 #3

Congress - Hearings/Markups - Senate Finance Committee: "Drug Pricing in America: A Prescription for Change, Part III" - Tuesday, April 9, 2019: The Senate Finance Committee continued its drug pricing series by...more

4/16/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare for All , OMB , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Trump Administration

Washington Healthcare Update April 2019 #2

Coming Week’s Highlights: Congress will continue to examine drug pricing; on Tuesday, the Senate Finance Committee will hold the third in a series of hearings, this one focused on pharmacy benefit managers (PBMs). The House...more

4/9/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , OMB , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Popular , Prescription Drugs

Washington Healthcare Update April 2019

Upcoming Hearings - Tuesday, April 2, 2019 - House Committee on Energy and Commerce: “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs” - The Subcommittee on Oversight and Investigations of the...more

4/2/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Drug Pricing , Food and Drug Administration (FDA) , GAO , OIG , Opioid , Pharmacy Benefit Manager (PBM) , Popular , Prescription Drugs

Washington Healthcare Update March 2019 #4

Upcoming Hearings - Tuesday, March 26, 2019 - House Committee on the Budget: “Department of Health and Human Services FY2020 Budget” - The House Committee on the Budget will hold a hearing examining the proposed...more

3/26/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , OIG , OMB , Opioid , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Washington Healthcare Update March 2019 #3

Upcoming Hearings - Tuesday, March 26, 2019 - Senate Committee on Health, Education, Labor and Pensions (HELP): “Implementing the 21st Century Cures Act: Making Electronic Health Information Available to Patients and...more

3/19/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Cost-Sharing , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Washington Healthcare Update March 2019 #2

Coming Week’s Highlights: CMS seeks recommendations that allow Americans to purchase health insurance across state lines, House to hold hearings on the 2020 HHS budget and lowering the cost of prescription drugs....more

3/12/2019 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Nursing Homes , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update March 2019 #1

Upcoming Hearings - Tuesday, March 5, 2019 - Senate Committee on Health, Education, Labor and Pensions (HELP): “Vaccines Save Lives: What is Driving Preventable Disease Outbreaks?” - The Senate Committee on Health,...more

3/5/2019 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Comment Period , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance Portability and Accountability Act (HIPAA) , Medicare , OMB , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Washington Healthcare Update February 2019 #4

Upcoming Hearings - Tuesday, Feb. 26, 2019 - Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part II” - The second hearing in a series on drug pricing in the Senate Finance Committee...more

2/26/2019 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HELP , Medicare Advantage , Medicare Part D , OMB , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Vaccinations

Washington Healthcare Update February 2019 #3

Upcoming Hearings - Tuesday, Feb. 26, 2019 - Senate Finance Committee: “TBA Hearing on Drug Pricing” - The second hearing in a series on drug pricing in the Senate Finance Committee will include the testimonies of...more

2/19/2019 / Centers for Medicare & Medicaid Services (CMS) , Comment Period , Department of Health and Human Services (HHS) , Drug Pricing , Health Care Providers , Medicare , Medicare Part D , OMB , Opioid , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Stephanie Kennan

McGuireWoods LLP

Readers' Choice Awards

Popular Topics by This Author

Latest Posts › Prescription Drugs